[ U.S. CDMRP – Lung Cancer Research Program Concept Award | Research Funding ]
Event details
| Date | 27.05.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Lung Cancer Research Program (LCRP) Awards. The LCRP Concept Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer. The Concept Award is not intended to support an incremental progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation.
In addition, all applications for LCRP funding must specifically address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY20 LCRP Topic Areas are listed at the end of this announcement.
Funding: max. $100’000
Duration: 1 year
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 27-May-2020, 5:00 p.m. EST
Full Application Deadline: 10-Jun-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-LCRP-CA
Further information
FY20 Areas of Emphasis
In addition, all applications for LCRP funding must specifically address at least one of the Areas of Emphasis as directed by Congress and have direct relevance to military health. The FY20 LCRP Topic Areas are listed at the end of this announcement.
Funding: max. $100’000
Duration: 1 year
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 27-May-2020, 5:00 p.m. EST
Full Application Deadline: 10-Jun-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-LCRP-CA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-LCRP-CA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY20 Areas of Emphasis
- Identify innovative strategies for prevention of the occurrence of lung cancer.
- Identify innovative strategies for the screening and early detection of lung cancer.
- Understand the molecular mechanisms of initiation and progression to lung cancer.
- Understand contributors to lung cancer development other than tobacco.
- Identify innovative strategies for the treatment of lung cancer.
- Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer.
- Develop or optimize prognostic or predictive markers to assist with therapeutic decision-making.
- Understand mechanisms of resistance to treatment (primary and secondary).
- Identify innovative strategies for lung cancer care delivery (disparities/clinical management/ surveillance/symptom management).
Practical information
- General public
- Free